Stay updated on RAS and Coagulopathy in COVID19 Clinical Trial
Sign up to get notified when there's something new on the RAS and Coagulopathy in COVID19 Clinical Trial page.

Latest updates to the RAS and Coagulopathy in COVID19 Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page’s displayed software/version revision at the bottom was updated from v3.5.2 to v3.5.3, reflecting a site release rather than a change to the study record.SummaryDifference0.1%

- Check18 days agoChange Detected- Revision updated from v3.5.0 to v3.5.2. No other content changes are reflected in the provided inputs.SummaryDifference0.1%

- Check25 days agoNo Change Detected
- Check47 days agoChange DetectedAdded site revision v3.5.0 and removed revision v3.4.3. These updates pertain to the page's versioning metadata rather than its study content.SummaryDifference0.1%

- Check54 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check82 days agoChange DetectedAdded Revision: v3.4.2. Removed older notices about government funding and prior Revision: v3.4.1.SummaryDifference0.4%

- Check90 days agoChange DetectedA site-wide notice regarding government funding and NIH operations status has been added, and the site version has been updated from v3.4.0 to v3.4.1. This does not modify the study details, eligibility criteria, or results.SummaryDifference0.4%

Stay in the know with updates to RAS and Coagulopathy in COVID19 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RAS and Coagulopathy in COVID19 Clinical Trial page.